Premium
Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists
Author(s) -
Pink A.E.,
Smith C.H.
Publication year - 2017
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15645
Subject(s) - ustekinumab , ixekizumab , medicine , secukinumab , adalimumab , infliximab , psoriasis , etanercept , efalizumab , dermatology , daclizumab , psoriatic arthritis , immunology , plaque psoriasis , tumor necrosis factor alpha , monoclonal antibody , antibody